BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35221041)

  • 1. Subtyping intestinal metaplasia in patients with chronic atrophic gastritis: an interobserver variability study.
    Lerch JM; Pai RK; Brown I; Gill AJ; Jain D; Kővári B; Kushima R; Sheahan K; Slavik T; Srivastava A; Lauwers GY; Langner C
    Pathology; 2022 Apr; 54(3):262-268. PubMed ID: 35221041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interobserver agreement of estimating the extent of intestinal metaplasia in patients with chronic atrophic gastritis.
    Lerch JM; Pai RK; Brown I; Gill AJ; Jain D; Kővári B; Kushima R; Sheahan K; Slavik T; Srivastava A; Lauwers GY; Langner C
    Virchows Arch; 2022 Jun; 480(6):1277-1281. PubMed ID: 34904185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer.
    den Hoed CM; Holster IL; Capelle LG; de Vries AC; den Hartog B; Ter Borg F; Biermann K; Kuipers EJ
    Endoscopy; 2013; 45(4):249-56. PubMed ID: 23533073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems.
    Isajevs S; Liepniece-Karele I; Janciauskas D; Moisejevs G; Putnins V; Funka K; Kikuste I; Vanags A; Tolmanis I; Leja M
    Virchows Arch; 2014 Apr; 464(4):403-7. PubMed ID: 24477629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.
    Capelle LG; de Vries AC; Haringsma J; Ter Borg F; de Vries RA; Bruno MJ; van Dekken H; Meijer J; van Grieken NC; Kuipers EJ
    Gastrointest Endosc; 2010 Jun; 71(7):1150-8. PubMed ID: 20381801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective.
    Kapadia CR
    J Clin Gastroenterol; 2003; 36(5 Suppl):S29-36; discussion S61-2. PubMed ID: 12702963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adequacy of endoscopic recognition and surveillance of gastric intestinal metaplasia and atrophic gastritis: A multicentre retrospective study in low incidence countries.
    Honing J; Keith Tan W; Dieninyte E; O'Donovan M; Brosens L; Weusten B; di Pietro M
    PLoS One; 2023; 18(6):e0287587. PubMed ID: 37352223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reproducibility of histopathologic diagnosis of precursor lesions of gastric carcinoma in three Latin American countries].
    Kasamatsu E; Bravo LE; Bravo JC; Aguirre-García J; Flores-Luna L; Nunes-Velloso Mdel C; Hernández-Suárez G
    Salud Publica Mex; 2010; 52(5):386-90. PubMed ID: 21031244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic evaluation of gastric intestinal metaplasia in non-neoplastic biopsy specimens: Accuracy and interobserver reliability among general pathologists and pathology residents.
    Laohawetwanit T; Wanpiyarat N; Lerttanatum N; Apornvirat S; Kantasiripitak C; Atiroj N; Pisutpunya A; Phairintr P; Suttichan K; Poungmeechai N; Tassanawarawat T; Chumponpanich N; Khueankaeo C; Chaijitrawan P; Sooksaen P; Stithsuksanoh C; Thinpanja W; Kaewnopparat W
    Ann Diagn Pathol; 2024 Jun; 70():152284. PubMed ID: 38422806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single vial is enough in the absence of endoscopic suspected intestinal metaplasia - less is more!
    Castro R; Esposito G; Libânio D; Afonso L; Annibale B; Dinis-Ribeiro M; Pimentel-Nunes P
    Scand J Gastroenterol; 2019 May; 54(5):673-677. PubMed ID: 31084230
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastric intestinal metaplasia and gastric cancer prevention: Watchful waiting.
    Khazaaleh S; Alomari M; Rashid MU; Castaneda D; Castro FJ
    Cleve Clin J Med; 2024 Jan; 91(1):33-39. PubMed ID: 38167394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous Recognition of Atrophic Gastritis and Intestinal Metaplasia on White Light Endoscopic Images Based on Convolutional Neural Networks: A Multicenter Study.
    Lin N; Yu T; Zheng W; Hu H; Xiang L; Ye G; Zhong X; Ye B; Wang R; Deng W; Li J; Wang X; Han F; Zhuang K; Zhang D; Xu H; Ding J; Zhang X; Shen Y; Lin H; Zhang Z; Kim JJ; Liu J; Hu W; Duan H; Si J
    Clin Transl Gastroenterol; 2021 Aug; 12(8):e00385. PubMed ID: 34342293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnifying endoscopy with narrow-band imaging for diagnosis of subtype of gastric intestinal metaplasia.
    Kanemitsu T; Uedo N; Ono T; Nimura S; Hasegawa R; Imamura K; Ohtsu K; Ono Y; Miyaoka M; Ueki T; Tanabe H; Ohta A; Iwashita A; Yao K
    J Gastroenterol Hepatol; 2023 Jan; 38(1):94-102. PubMed ID: 36268636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance strategy of atrophic gastritis and intestinal metaplasia in a country with a high prevalence of gastric cancer.
    Shin WG; Kim HU; Song HJ; Hong SJ; Shim KN; Sung IK; Kim JG;
    Dig Dis Sci; 2012 Mar; 57(3):746-52. PubMed ID: 21984437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can neopterin be a useful immune biomarker for differentiating gastric intestinal metaplasia and gastric atrophy from non-atrophic non-metaplastic chronic gastritis?
    Kutluana U; Kilciler AG; Mizrak S; Dilli U
    Gastroenterol Hepatol; 2019 May; 42(5):289-295. PubMed ID: 30795853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.
    Pimentel-Nunes P; Libânio D; Marcos-Pinto R; Areia M; Leja M; Esposito G; Garrido M; Kikuste I; Megraud F; Matysiak-Budnik T; Annibale B; Dumonceau JM; Barros R; Fléjou JF; Carneiro F; van Hooft JE; Kuipers EJ; Dinis-Ribeiro M
    Endoscopy; 2019 Apr; 51(4):365-388. PubMed ID: 30841008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
    Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical enhancement imaging versus acetic acid for detecting gastric intestinal metaplasia: A randomized, comparative trial.
    Ji R; Liu J; Zhang MM; Li YY; Zuo XL; Wang X; Li YQ
    Dig Liver Dis; 2020 Jun; 52(6):651-657. PubMed ID: 32265143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Precancerous conditions in gastric cancer (II): relationship between atrophic gastritis-intestinal metaplasia-gastric dysplasia-gastric carcinoma].
    Martínez Díaz FJ; Canteras Jordana M; Ortuño Pacheco G
    Rev Esp Enferm Dig; 1991 Jul; 80(1):17-21. PubMed ID: 1931240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors to improve the interobserver agreement for gastric atrophy and intestinal metaplasia: consensus of definition and criteria.
    Kim SS; Kook MC; Shin OR; Kim HS; Bae HI; Seo AN; Park DY; Choi IJ; Kim YI; Nam BH; Kim S
    Histopathology; 2018 Apr; 72(5):838-845. PubMed ID: 29161756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.